CIK 0001840877 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Envoy Medical, Inc.
Sign in to watch- Ticker
- COCH
- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 861369123
- Phone
- 651-361-8000
- Business address
- 4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE, MN, 55110
- Former names
- Anzu Special Acquisition Corp I
Securities
- COCH Class A Common Stock Nasdaq
- COCHW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-24 | Potashnick Robert CAO & VP of Finance | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2026-06-19 | Lucas Brent T. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +1,000,000 | 1,000,000 | ||
| 2026-06-19 | Lucas Brent T. Chief Executive Officer | Grant or award · Restricted Stock Units | +1,000,000 | 1,000,000 | ||
| 2026-05-29 | Lucas Brent T. Chief Executive Officer | Grant or award | +32,856 | $0.60 | $20K | 329,946 |
| 2026-04-15 | McKhann Chas Director | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2026-02-12 | TAYLOR GLEN A 10% owner | Purchase | +18,750,000 | $0.40 | $7.5M | 21,703,607 |
| 2026-02-12 | TAYLOR GLEN A 10% owner | Purchase · Warrant Shares (Series A-1) | +11,250,000 | 11,250,000 | ||
| 2026-02-12 | TAYLOR GLEN A 10% owner | Purchase · Warrant Shares (Series A-2) | +18,750,000 | 18,750,000 | ||
| 2026-02-12 | Patel Mona Chetan Director | Purchase | +312,500 | $0.40 | $125K | 332,500 |
| 2026-02-12 | Patel Mona Chetan Director | Purchase · Warrant (right to buy) | +187,500 | 187,500 | ||
| 2026-02-12 | Patel Mona Chetan Director | Purchase · Warrant (right to buy) | +312,500 | 312,500 | ||
| 2026-02-12 | Potashnick Robert Interim CFO | Purchase | +212,500 | $0.40 | $85K | 212,500 |
| 2026-02-12 | Potashnick Robert Interim CFO | Purchase · Warrant (right to buy) | +127,500 | 127,500 | ||
| 2026-02-12 | Potashnick Robert Interim CFO | Purchase · Warrant (right to buy) | +212,500 | 212,500 | ||
| 2026-02-12 | Kantor Susan Director | Purchase | +96,150 | $0.40 | $38K | 174,037 |
| 2026-02-12 | Kantor Susan Director | Purchase · Warrant (right to buy) | +57,690 | 57,690 | ||
| 2026-02-12 | Kantor Susan Director | Purchase · Warrant (right to buy) | +96,150 | 96,150 | ||
| 2026-02-12 | BRYNELSEN CHARLES Director | Purchase | +1,000,000 | $0.40 | $400K | 1,050,000 |
| 2026-02-12 | BRYNELSEN CHARLES Director | Purchase · Warrant (right to buy) | +600,000 | 600,000 | ||
| 2026-02-12 | BRYNELSEN CHARLES Director | Purchase · Warrant (right to buy) | +1,000,000 | 1,000,000 |
Page 1 of 6 · 103 trades